Clinical Trial Update: Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo [Phase 4]

View source ↗

Summary

Post-marketing Phase 4 trial comparing residual effects of extended-release zolpidem and eszopiclone versus placebo in adults with insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eszopiclone (eszopiclone)
• Zolpidem tartrate extended-release (zolpidem)

Snippet

Sponsor: Sanofi | Conditions: Insomnia | Phase 4 | Status: COMPLETED